In the OVCAR5 model, tumor weight was significantly lower in mice given L-Grb2 and paclitaxel (0.17 g ± 0.10 g, p < 0.05) than in control mice (0.99 g ± 0.35 g) (Figure 1A). This evidence concerns the gene GRB2 and neoplasm.